Ticker
EOLSCompany Name
EVOLUS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -61.99M | -22.31% | $ 277.94M |
3/31/2025 | $ -56.2M | -20.4% | $ 275.46M |
12/31/2024 | $ -50.42M | -18.94% | $ 266.27M |
9/30/2024 | $ -55.46M | -22.33% | $ 248.33M |
6/30/2024 | $ -53.21M | -22.43% | $ 237.26M |
3/31/2024 | $ -60M | -27.31% | $ 219.7M |
12/31/2023 | $ -61.69M | -30.52% | $ 202.09M |
9/30/2023 | $ -63.02M | -34.11% | $ 184.73M |
6/30/2023 | $ -66.37M | -39.36% | $ 168.61M |
3/31/2023 | $ -71.7M | -45.84% | $ 156.43M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for EVOLUS INC is calculated as follows: Net Inc. Cmn. [ $ -66.83M ] / Revenues [ $ 55.41M ]
(=) Net % [ -120.6% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.2K |
---|---|
min | -64.23% |
max | 69.74% |
average | 4.77% |
median | 5.24% |
std | 19.84% |